These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 8302479)

  • 1. Correction of hyperlipidaemia in a nephrotic patient during an episode of anuria.
    Tornero F; Torralbo A; Portolés J; Barrientos A
    Nephrol Dial Transplant; 1993; 8(11):1307. PubMed ID: 8302479
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperlipidaemia of the nephrotic syndrome--the search for a nephrotic factor.
    Joven J; Vilella E
    Nephrol Dial Transplant; 1995; 10(3):314-6. PubMed ID: 7792024
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of fibre in the treatment of secondary hyperlipidaemia in nephrotic patients.
    Gentile MG; Ciceri R; Manna GM; Delle Fave A; Zanoni C; Raschioni E; Combi S; Maiocchi V; D'Amico G
    Eur J Clin Nutr; 1995 Oct; 49 Suppl 3():S239-41. PubMed ID: 8549536
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.
    Wheeler DC
    J Nephrol; 2001; 14 Suppl 4():S70-5. PubMed ID: 11798150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on hyperlipidemia in nephrotic syndrome].
    PEZOLD FA
    Klin Wochenschr; 1959 Feb; 37(3):132-40. PubMed ID: 13642720
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Hyperlipidaemia in renal disease.
    Vosnides G; Cameron JS
    Med J Aust; 1974 Dec; 2(23):855. PubMed ID: 4453249
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal origin of hyperlipidemia in nephrotic syndrome].
    REUBI F; SCHMID A
    J Urol Medicale Chir; 1955; 61(5):304-10. PubMed ID: 13307722
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
    Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult nephrotic syndrome: non-specific strategies for treatment.
    Charlesworth JA; Gracey DM; Pussell BA
    Nephrology (Carlton); 2008 Feb; 13(1):45-50. PubMed ID: 18199102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origin and nature of anisotropic urinary lipids in the nephrotic syndrome.
    ZIMMER JG; DEWEY R; WATERHOUSE C; TERRY R
    Ann Intern Med; 1961 Feb; 54():205-14. PubMed ID: 13788521
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic management].
    Vanzetto G; Fouque D; Moulin B; Halimi S; Kessler M; Bayle F
    Nephrologie; 2000; 21(7):383-92. PubMed ID: 11200619
    [No Abstract]   [Full Text] [Related]  

  • 13. Astragalus mongholicus and Angelica sinensis compound alleviates nephrotic hyperlipidemia in rats.
    Li J; Yu L; Li N; Wang H
    Chin Med J (Engl); 2000 Apr; 113(4):310-4. PubMed ID: 11775225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amino acids in the nephrotic syndrome. Note 2. Aminoaciduria in the paranephritic nephrotic syndrome. Chromatographic observations].
    FIASCHI E; SCAVO D; MONTI G
    Rass Fisiopatol Clin Ter; 1960 Apr; 32():279-311. PubMed ID: 13699293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relapsing nephrotic syndrome in a diabetic patient with minimal change].
    García Donaire JA; Manzanera MI; Valentín MO; Espejo B; Gutiérrez Martínez E; Praga M
    Nefrologia; 2004; 24(2):179-82. PubMed ID: 15219093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some observations relating to the urinary excretion of aldosterone in the paranephritic nephrotic syndrome in the adult].
    CIAMPALINI L; IACOBELLI A; NUZZI R; MONTI G; LUZIETTI L
    Minerva Nefrol; 1960; 7():116-20. PubMed ID: 13693589
    [No Abstract]   [Full Text] [Related]  

  • 17. New aspects of posttransplant nephrotic syndrome: clinicopathologic correlations with outcomes.
    Yakupoğlu U; Baranowska-Daca E; Suki WN; Truong LD
    Transplant Proc; 2004; 36(1):139-43. PubMed ID: 15013326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications of the nephrotic syndrome].
    Garibotto G; Giannoni M; Salvatore F
    G Ital Nefrol; 2003; 20(1):49-60. PubMed ID: 12647287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid disturbances in the nephrotic syndrome].
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Przegl Lek; 2003; 60(11):758-61. PubMed ID: 15058052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperlipemia in nephrotic syndrome].
    GUARINI G
    Arch Maragliano Patol Clin; 1957 Dec; 13(6):1673-707. PubMed ID: 13535006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.